Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1968 Oct 12;4(5623):87–89. doi: 10.1136/bmj.4.5623.87

Medullary Carcinoma and Thyrocalcitonin*

M Tubiana, G Milhaud, G Coutris, J Lacour, C Parmentier, B Bok
PMCID: PMC1912102  PMID: 5748583

Abstract

Seven patients with medullary carcinoma of the thyroid were investigated, and the thyrocalcitonin activity of the primary tumours, metastatic deposits, and the serum was estimated.

Medullary carcinomas of the thyroid with amyloid stroma contain 100 to 600 times more thyrocalcitonin than normal thyroid tissue, and lymph nodes with metastatic deposits are equally rich in the hormone. High values of thyrocalcitonin are also found in the blood of these patients. Medullary carcinoma of the thyroid with amyloid stroma is the first disease to be recognized in which there is hypersecretion of thyrocalcitonin.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aliapoulios M. A., Voelkel E. F., Munson P. L. Assay of human thyroid glands for thyrocalcitonin activity. J Clin Endocrinol Metab. 1966 Aug;26(8):897–901. doi: 10.1210/jcem-26-8-897. [DOI] [PubMed] [Google Scholar]
  2. BAGHDIANTZ A., FOSTER G. V., EDWARDS A., KUMAR M. A., SLACK E., SOLIMAN H. A., MACINTYRE I. EXTRACTION AND PURIFICATION OF CALCITONIN. Nature. 1964 Sep 5;203:1027–1028. doi: 10.1038/2031027a0. [DOI] [PubMed] [Google Scholar]
  3. Gérard-Marchant R. L'épithélioma médullaire à stroma amyloïde du corps thyroïde. J Chir (Paris) 1965 Oct;90(4):337–339. [PubMed] [Google Scholar]
  4. HAZARD J. B., HAWK W. A., CRILE G., Jr Medullary (solid) carcinoma of the thyroid; a clinicopathologic entity. J Clin Endocrinol Metab. 1959 Jan;19(1):152–161. doi: 10.1210/jcem-19-1-152. [DOI] [PubMed] [Google Scholar]
  5. Ljungberg O. Medullary carcinoma of the human thyroid gland. Autoradiographic localization of radioiodine. Acta Pathol Microbiol Scand. 1966;68(4):476–480. doi: 10.1111/apm.1966.68.4.476. [DOI] [PubMed] [Google Scholar]
  6. Meyer J. S., Abdel-Bari W. Granules and thyrocalcitonin-like activity in medullary carcinoma of the thyroid gland. N Engl J Med. 1968 Mar 7;278(10):523–529. doi: 10.1056/NEJM196803072781002. [DOI] [PubMed] [Google Scholar]
  7. Milhaud G., Tubiana M., Parmentier C., Coutris G. Epithélioma de la thyroïde sécrétant de la thyrocalcitonine. C R Acad Sci Hebd Seances Acad Sci D. 1968 Feb 5;266(6):608–610. [PubMed] [Google Scholar]
  8. Tashjian A. H., Jr, Frantz A. G., Lee J. B. Pseudohypoparathyroidism: assays of parathyroid hormone and thyrocalcitonin. Proc Natl Acad Sci U S A. 1966 Oct;56(4):1138–1142. doi: 10.1073/pnas.56.4.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Williams E. D., Brown C. L., Doniach I. Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroid. J Clin Pathol. 1966 Mar;19(2):103–113. doi: 10.1136/jcp.19.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Williams E. D., Karim S. M., Sandler M. Prostaglandin secretion by medullary carcinoma of the thyroid. A possible cause of the associated idarrhoea. Lancet. 1968 Jan 6;1(7532):22–23. doi: 10.1016/s0140-6736(68)90010-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES